Osteoarthritis Regenerative Therapies Market to Reach $5.88 Billion by 2030 with Strong Growth
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Regenerative Therapies For Osteoarthritis Market Over The 2026–2030 Period?
The regenerative therapies for osteoarthritis market has experienced significant growth in recent years. This market is expected to expand from $3.04 billion in 2025 to $3.46 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.9%. Historically, this growth can be attributed to several factors including the rising prevalence of osteoarthritis, the expansion of the aging population, the limitations inherent in pain relief drugs, an increase in sports injuries, and the growing demand for non-surgical treatments.
The regenerative therapies for osteoarthritis market size is anticipated to expand significantly in the coming years. It is projected to achieve a value of $5.88 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.2%. This expansion within the forecast period is driven by increased adoption of biologic therapy, the growth of regenerative clinics, stronger clinical evidence, a rising demand for cartilage restoration, and greater investment in cell therapy research. Prominent trends for the forecast period include stem cell based joint repair therapies, platelet rich plasma treatment protocols, scaffold based cartilage regeneration, minimally invasive regenerative injections, and personalized biologic therapy plans.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33292&type=smp
What Underlying Factors Are Accelerating The Growth Of The Regenerative Therapies For Osteoarthritis Market?
The escalating incidence of musculoskeletal disorders is projected to boost the expansion of the regenerative therapies for the osteoarthritis market moving forward. These conditions involve affections of the bones, joints, muscles, and connective tissues, resulting in discomfort and limitations in mobility and dexterity. The increasing prevalence of musculoskeletal disorders is primarily driven by an aging population, given that older demographics experience higher rates of joint degeneration and inflammatory issues impacting musculoskeletal structures. The growing occurrence of musculoskeletal disorders consequently heightens the demand for regenerative therapies, as they present sophisticated treatment options for joint reconstruction and tissue repair in patients suffering from osteoarthritis. For instance, in January 2024, the Office for Health Improvement & Disparities, a UK-based government agency, reported that in 2023, 18.4% of individuals aged 16 and above stated they had a long-term musculoskeletal (MSK) condition, an increase from 17.6% in 2022. Therefore, the rising prevalence of musculoskeletal disorders is propelling the growth of the regenerative therapies for the osteoarthritis market.
How Is The Regenerative Therapies For Osteoarthritis Market Segmented Across Key Categories?
The regenerative therapies for osteoarthritis market covered in this report is segmented –
1) By Therapy Type: Stem Cell Therapy; Platelet Rich Plasma Therapy; Tissue Engineering; Gene Therapy; Other Therapy Types
2) By Distribution Channel: Direct Manufacturer Supply; Hospital And Clinic Procurement Channels; Specialty Medical Distributors
3) By Application: Knee Osteoarthritis; Hip Osteoarthritis; Hand Osteoarthritis; Other Applications
4) By End User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End Users
Subsegments:
1) By Stem Cell Therapy: Autologous Stem Cell Therapy; Allogeneic Stem Cell Therapy; Mesenchymal Stem Cell Therapy; Adipose Derived Stem Cell Therapy; Bone Marrow Derived Stem Cell Therapy
2) By Platelet Rich Plasma Therapy: Leukocyte Rich Platelet Rich Plasma Therapy; Leukocyte Poor Platelet Rich Plasma Therapy; Activated Platelet Rich Plasma Therapy; Non Activated Platelet Rich Plasma Therapy; Pure Platelet Rich Plasma Therapy
3) By Tissue Engineering: Scaffold Based Tissue Engineering; Hydrogel Based Tissue Engineering; Biodegradable Matrix Tissue Engineering; Cell Seeded Tissue Engineering; Three Dimensional Tissue Engineering
4) By Gene Therapy: Viral Vector Gene Therapy; Non Viral Vector Gene Therapy; In Vivo Gene Therapy; Ex Vivo Gene Therapy; Targeted Gene Therapy
5) By Other Therapy Types: Hyaluronic Acid Therapy; Growth Factor Therapy; Chondrocyte Implantation Therapy; Peptide Based Therapy; Immunomodulatory Therapy
Which Upcoming Trends Are Expected To Influence The Regenerative Therapies For Osteoarthritis Market?
Major companies in the regenerative therapies for the osteoarthritis market are focusing on developing advanced solutions, such as allogeneic mesenchymal stem cell (MSC) osteoarthritis therapies, to meet the increasing demand for disease-modifying treatments. Allogeneic mesenchymal stem cell (MSC) osteoarthritis therapies employ donor-sourced stem cells to modulate inflammation and support cartilage regeneration in affected joints, offering a ready-to-use, scalable option compared to patient-derived cells, which allows for standardized dosing and wider adoption. For example, in December 2025, Cipla Limited, an India-based pharmaceutical company, partnered with Stempeutics Research, an India-based research and product development company, to launch Ciplostem, an innovative allogeneic MSC therapy for knee osteoarthritis. This therapy is given as a single-dose intra-articular injection that contains 25 million cultured adult human bone marrow-derived MSCs co-formulated with hyaluronic acid, engineered to function at the cellular level to reduce inflammation, slow disease progression, enhance joint function, and help preserve cartilage quality in Grade II and III knee OA patients. The key characteristics of this therapy include its off-the-shelf availability (removing the need for individualized preparation), cellular-level action as opposed to just symptomatic relief, and the potential for prolonged improvement in joint health compared with standard regimens.
Which Companies Are Leading Innovation In The Regenerative Therapies For Osteoarthritis Market?
Major companies operating in the regenerative therapies for osteoarthritis market are Stryker Corporation, Smith & Nephew plc, MiMedx Group Inc, Anika Therapeutics Inc, Regentis Biomaterials Ltd, Zomedica Corp, Biosplice Therapeutics Inc, Tissue Regenix Group plc, Co.don AG, MEDIPOST Co Ltd, Ampio Pharmaceuticals Inc, Kolon TissueGene Inc, Mesoblast Limited, Orgenesis Inc, Hyalex Orthopaedics Limited, Orthocell Limited, Jellagen Limited, Hyalogic LLC, Bionaut Labs Inc, and Regeneus Limited.
Read the full regenerative therapies for osteoarthritis market report here:
Which Region Is Expected To Experience The Fastest Growth In The Regenerative Therapies For Osteoarthritis Market?
North America was the largest region in the regenerative therapies for osteoarthritis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the regenerative therapies for osteoarthritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Regenerative Therapies For Osteoarthritis Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=33292&type=smp
Browse Through More Reports Similar to the Global Regenerative Therapies For Osteoarthritis Market 2026, By The Business Research Company
Regenerative Medicine For Cartilage Market Report 2026
Orthopedic Regenerative Surgical Products Market Report 2026
Osteoarthritis Market Report 2026
https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
